−2.71USD
−4.13 MUSD
2.54 MUSD
1.25 M
About Xenetic Biosciences, Inc.
Sector
CEO
Jeffrey F. Eisenberg
Headquarters
Framingham
Website
Employees (FY)
4
Founded
2011
FIGI
BBG00PSSNL64
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
